Characteristics of Female Non-Muscle-Invasive Bladder Cancer in Taiwan: Association with Upper Tract Urothelial Carcinoma and End-Stage Renal Disease

Urology

Volumn 71, Issue 6, 2008, Pages 1155-1160

  Chen, Chung Hsin ^a,b   Shun, Chia Tung ^a   Huang, Kuo How ^a   Huang, Chao Yuan ^a   Yu, Hong Jeng ^a   Pu, Yeong Shiau ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b TAOYUAN GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER GRADING; CANCER INVASION; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CIGARETTE SMOKING; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SEX DIFFERENCE; SURGICAL TECHNIQUE; TAIWAN; TREATMENT OUTCOME; TUMOR GROWTH; URETHRA CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASMS, MULTIPLE PRIMARY; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; TAIWAN; URETERAL NEOPLASMS; URINARY BLADDER NEOPLASMS;

EID: 44649175038     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2007.11.140     Document Type: Article

References (26)

1. Puente D., Malats N., Cecchini L., et al. Gender-related differences in clinical and pathological characteristics and therapy of bladder cancer. Eur Urol 43 (2003) 53-62
2. Hartge P., Harvey E.B., Linehan W.M., et al. Unexplained excess risk of bladder cancer in men. J Natl Cancer Inst 82 (1990) 1636-1640
3. Mungan N.A., Aben K.K., Schoenberg M.P., et al. Gender differences in stage-adjusted bladder cancer survival. Urology 55 (2000) 876-880
4. Heney N.M., Ahmed S., Flanagan M.J., et al. Superficial bladder cancer: progression and recurrence. J Urol 130 (1983) 1083-1086
5. Busch C., and Algaba F. The WHO/ISUP 1998 and WHO 1999 systems for malignancy grading of bladder cancer: scientific foundation and translation to one another and previous systems. Virchows Arch 441 (2002) 105-108
6. Sobin L.H., and Wittekind C. International Union Against Cancer (UICC). Urinary bladder. TNM: Classification of Malignant Tumors (1997), Wiley-Liss, New York 187-190
7. Chen C.H., Shun C.T., Huang K.H., et al. Stopping smoking might reduce tumour recurrence in nonmuscle-invasive bladder cancer. BJU Int 100 (2007) 281-286
8. Lamm D.L., Blumenstein B.A., Crissman J.D., et al. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study. J Urol 163 (2000) 1124-1129
9. Fleshner N.E., Herr H.W., Stewart A.K., et al. The National Cancer Data Base report on bladder carcinoma. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 78 (1996) 1505-1513
10. Herr H.W. Restaging transurethral resection of high risk superficial bladder cancer improves the initial response to bacillus Calmette-Guerin therapy. J Urol 174 (2005) 2134-2137
11. Chang C.H., Wang Y.M., Yang A.H., et al. Rapidly progressive interstitial renal fibrosis associated with Chinese herbal medications. Am J Nephrol 21 (2001) 441-448
12. Yang C.S., Lin C.H., Chang S.H., et al. Rapidly progressive fibrosing interstitial nephritis associated with Chinese herbal drugs. Am J Kidney Dis 35 (2000) 313-318
13. Nortier J.L., Martinez M.C., Schmeiser H.H., et al. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N Engl J Med 342 (2000) 1686-1692
14. Mungan N.A., Kiemeney L.A., van Dijck J.A., et al. Gender differences in stage distribution of bladder cancer. Urology 55 (2000) 368-371
15. Kiemeney L.A., Coebergh J.W., Koper N.P., et al. Bladder cancer incidence and survival in the south-eastern part of The Netherlands, 1975-1989. Eur J Cancer 30A (1994) 1134-1137
16. Huang P.C., Huang C.Y., Huang S.W., et al. High incidence of and risk factors for metachronous bilateral upper tract urothelial carcinoma in Taiwan. Int J Urol 13 (2006) 864-869
17. Matsui Y., Utsunomiya N., Ichioka K., et al. Risk factors for subsequent development of bladder cancer after primary transitional cell carcinoma of the upper urinary tract. Urology 65 (2005) 279-283
18. Hall M.C., Womack S., Sagalowsky A.I., et al. Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients. Urology 52 (1998) 594-601
19. Raman J.D., Ng C.K., Boorjian S.A., et al. Bladder cancer after managing upper urinary tract transitional cell carcinoma: predictive factors and pathology. BJU Int 96 (2005) 1031-1035
20. Taiwan Cancer Registry: Annual Report of Taiwan Cancer Registry. Available: http://crs.cph.ntu.edu.tw/crs_c/annual html, 2003. [accessed on September 7, 2007].
21. Chang C.H., Yang C.M., and Yang A.H. Renal diagnosis of chronic hemodialysis patients with urinary tract transitional cell carcinoma in Taiwan. Cancer 109 (2007) 1487-1492
22. Chen Y.C., Su H.J., Guo Y.L., et al. Arsenic methylation and bladder cancer risk in Taiwan. Cancer Causes Control 14 (2003) 303-310
23. Marsit C.J., Karagas M.R., Danaee H., et al. Carcinogen exposure and gene promoter hypermethylation in bladder cancer. Carcinogenesis 27 (2006) 112-116
24. Hsieh F.I., Pu Y.S., Chern H.D., et al. Genetic polymorphisms of N-acetyltransferase 1 and 2 and risk of cigarette smoking-related bladder cancer. Br J Cancer 81 (1999) 537-541
25. Wen C.P., Levy D.T., Cheng T.Y., et al. Smoking behaviour in Taiwan, 2001. Tob Control 14 Suppl 1 (2005) i51-i55
26. Stewart J.H., Buccianti G., Agodoa L., et al. Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: analysis of data from the United States, Europe, and Australia and New Zealand. J Am Soc Nephrol 14 (2003) 197-207